ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 890

$540K Total Retail Price of All Prescriptions

Rank: 223 out of 890

671 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 671 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

15% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 9,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 547 433 1 1
LISINOPRIL 509 334 2 4
METFORMIN HCL 486 372 3 6
SIMVASTATIN 472 362 4 5
HYDROCODONE-ACETAMINOPHEN 450 247 S3 5 3
OMEPRAZOLE 326 241 6 8
CEFUROXIME 312 195 7 168
HYDROCHLOROTHIAZIDE 298 223 8 9
LEVOTHYROXINE SODIUM 281 197 9 2
LOVASTATIN 257 144 10 46
FUROSEMIDE 221 141 11 7
NEXIUM 216 75 12 14
POTASSIUM CHLORIDE 210 148 13 11
GLYBURIDE-METFORMIN HCL 201 128 R 14 115
ZOLPIDEM TARTRATE 199 143 15 19
PREDNISONE 171 102 16 47
MELOXICAM 169 119 17 18
CRESTOR 155 107 18 25
PRAVASTATIN SODIUM 152 107 19 10
RANITIDINE HCL 152 108 19 49
CARVEDILOL 149 131 21 22
PAROXETINE HCL 132 66 22 68
AMLODIPINE BESYLATE-BENAZEPRIL 130 103 23 41
AZITHROMYCIN 125 66 24 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 88 24 21
ENALAPRIL MALEATE 124 104 26 56
PROAIR HFA 121 78 27 55
GABAPENTIN 120 74 28 12
AMITRIPTYLINE HCL 116 92 R 29 43
TAMSULOSIN HCL 115 79 30 32
METOPROLOL SUCCINATE 114 79 31 17
SERTRALINE HCL 112 93 32 26
METOPROLOL TARTRATE 102 80 33 15
DIOVAN HCT 100 83 34 48
ADVAIR DISKUS 99 39 35 52
TRAMADOL HCL 98 80 36 16
BISOPROLOL-HYDROCHLOROTHIAZIDE 97 61 37 122
CITALOPRAM HBR 94 66 38 20
ALLOPURINOL 90 74 39 31
ATORVASTATIN CALCIUM 88 83 40 13
DIOVAN 86 58 41 33
CLOPIDOGREL 86 58 41 28
GLIPIZIDE XL 83 69 43 128
MINOCYCLINE HCL 82 56 44 350
CARISOPRODOL 80 17 R 45 69
WARFARIN SODIUM 75 41 46 24
LANTUS 74 53 47 50
CYMBALTA 74 65 47 45
BENAZEPRIL HCL 70 53 49 44
ISOSORBIDE MONONITRATE ER 69 59 50 60
VENTOLIN HFA 69 43 50 177
MECLIZINE HCL 66 50 52 97
PLAVIX 65 41 53 42
ESCITALOPRAM OXALATE 62 44 54 51
CLONIDINE HCL 62 52 54 35
GLYBURIDE 61 29 R 56 83
ALENDRONATE SODIUM 58 47 57 38
TRAZODONE HCL 57 26 58 40
NOVOLIN 70-30 56 30 59 199
TRIAMTERENE-HCTZ 55 42 60 61
INSULIN SYRINGE 55 37 60 99
GLIPIZIDE 53 29 62 62
PRAMIPEXOLE DIHYDROCHLORIDE 53 44 62 175
NAMENDA 52 52 64 36
BYSTOLIC 52 41 64 86
NIFEDIPINE ER 52 34 64 75
CIPROFLOXACIN HCL 51 36 67 58
LACTULOSE 50 28 68 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.